Catenin, beta (CTNNB1) Ultraspecific Antibody

Tested against >20,000 Human Proteins

$ 228.00$ 488.00

SKU: 1499-MSM13
Species: Human, Mouse and Rat
Tested Applications: Flow, IF, WB
Available Conjugates: Unconjugated
Isotype: Mouse IgG1, kappa
Mass Spec Validated?: Not MS Validated

 PDF Datasheet

Human, Mouse and Rat Anti-Catenin, beta (CTNNB1) Antibody Product Attributes

Species: Human, Mouse and Rat
Tested Applications: Flow, IF, WB.
Clonality: Monoclonal
Anti-Catenin, beta (CTNNB1) Antibody Clone: rCTNNB1/2173
Clone rCTNNB1/2173 Host and Isotype: Mouse IgG1, kappa
Anti-Human, Mouse and Rat Catenin, beta (CTNNB1) Positive Control Sample: HeLa or MCF-7 cells. Breast carcinoma
Cellular Localization of Antibody rCTNNB1/2173 Staining: Cell surface and cytoplasmic
Buffer and Stabilizer: 10mM PBS with 0.05% BSA & 0.05% azide. Also available without BSA & Azide.
Antibody Concentration: 200 ug/ml
Antibody Purification Method:Protein A/G purified from Bioreactor concentrate.
Immunogen: Recombinant full-length human beta-Catenin (CTNNB1) protein
Storage Conditions: Store at 2 to 8 C (refrigerate). Stable for 24 months when properly stored.

Catenin, beta (CTNNB1) Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-CTNNB1 antibody staining is expected to be primarily localized to the plasma membrane.

Observed Antibody Staining Data By Tissue Type:

Variations in Beta Catenin antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in bile duct cells in the liver, cells in the seminiferous ducts in testis, cells in the tubules in kidney, epidermal cells in the skin, exocrine glandular cells in the pancreas, glandular cells in the adrenal gland, appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, parathyroid gland, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, hepatocytes in liver, keratinocytes in skin, myocytes in heart muscle, myoepithelial cells in the breast, respiratory epithelial cells in the bronchus and nasopharynx, squamous epithelial cells in the cervix, uterine, esophagus, oral mucosa, tonsil and vagina, trophoblastic cells in the placenta and urothelial cells in the urinary bladder. More moderate antibody staining intensity was present in bile duct cells in the liver, cells in the seminiferous ducts in testis, cells in the tubules in kidney, epidermal cells in the skin, exocrine glandular cells in the pancreas, glandular cells in the adrenal gland, appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, parathyroid gland, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, hepatocytes in liver, keratinocytes in skin, myocytes in heart muscle, myoepithelial cells in the breast, respiratory epithelial cells in the bronchus and nasopharynx, squamous epithelial cells in the cervix, uterine, esophagus, oral mucosa, tonsil and vagina, trophoblastic cells in the placenta and urothelial cells in the urinary bladder. Low, but measureable presence of Beta Catenin could be seen in cells in the endometrial stroma in endometrium, cells in the glomeruli in kidney, cells in the molecular layer in cerebellum, endothelial cells in the cerebral cortex, fibroblasts in skin, glial cells in the caudate nucleus, cerebral cortex and hippocampus, hematopoietic cells in the bone marrow, Leydig cells in the testis, neuronal cells in the caudate nucleus, cerebral cortex and hippocampus, ovarian stroma cells in the ovary and Purkinje cells in the cerebellum. We were unable to detect Beta Catenin in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of Beta Catenin expression as measured by anti-Beta Catenin antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity +++ ++ +++ +++ +++ + +++ +++ +++ +++ +++ +++ +++ ++ +++ ++ + +++ +++
CTNNB1 Variability ++ ++ ++ + + +++ ++ ++ ++ + + ++ + + ++ + ++ ++ + ++

Limitations and Warranty

enQuire Bio’s product, Catenin, beta (CTNNB1) MonoSpecific Antibody, is available for Research Use Only (RUO-Only). This antibody is guaranteed to work for a period of two years when properly stored.
Size

,

Tag

Buffer and Stabilizer

Product Type

Host

Isotype

Applications

,

Species

Mass Spec Validated?

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Catenin, beta (CTNNB1) Ultraspecific Antibody

Tested against >20,000 Human Proteins

https://enquirebio.com/wp-content/uploads/2019/01/Anti-beta-Catenin Specificity Assay (Array)-300x120.jpghttps://enquirebio.com/wp-content/uploads/2019/01/beta-catenin staining HeLa confocal-300x300.jpghttps://enquirebio.com/wp-content/uploads/2019/01/beta-Catenin IHC human Breast Cancer (rCTNNB1 2173)-300x225.jpghttps://enquirebio.com/wp-content/uploads/2019/01/Anti-beta-Catenin(rCTNNB1 2173) Gel-259x300.jpghttps://enquirebio.com/wp-content/uploads/2018/06/enQuire-Bio-1499-MSM13-P0-anti-Catenin-beta-CTNNB1-antibody-1-300x120.jpeg